Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study

Objective To assess whether modifications in the night-time blood pressure fall caused by antihypertensive treatment predict the regression of end-organ damage of hypertension. Methods The analysis was performed in patients with essential hypertension and echocardiographically detected left ventricular hypertrophy involved in the SAMPLE study. For each patient, ambulatory blood pressure monitoring and echocardiographic determination of left ventricular mass index were performed at the end of a 4-week wash-out pretreatment period, after 3 and 12 months of treatment with lisinopril or with lisinopril plus hydrochlorothiazide and after a final 4-week placebo period. For each ambulatory blood pressure monitoring the 24 h average, daytime average (0600–2400 h), night-time average (2400–0600 h) and day–night difference was computed. The percentages of dipper and non-dipper patients (i.e. the patients with night blood pressure falls greater and less than 10% of the daytime average, respectively) were also computed. Results The reproducibility of the day–night difference was low, both for comparison of the pretreatment and final placebo periods (n = 170) and for comparison of the third and the 12th month of treatment (n = 180). The reproducibility of the dipper–non-dipper dichotomy was also low, 35–40% of patients becoming non-dippers if they were dippers and vice versa, both with and without treatment. The changes in left ventricular mass index after 12 months of treatment were significantly (P < 0.01) related to the changes in 24 h, daytime and night-time blood pressure (r always > 0.33), but this was not the case for the treatment-induced modification of the day–night difference (r = −0.03 and −0.008 for systolic and diastolic blood pressures, respectively). Conclusions Our results show that day–night blood pressure changes and the classification of patients into dippers and non-dippers are poorly reproducible over time. It also provides the first prospective evidence that treatment-induced changes in day–night blood pressure difference are not related to treatment-induced regression of left ventricular mass index, thus having a limited clinical significance.

[1]  E. Sandoya,et al.  Ambulatory Blood Pressure , 1999 .

[2]  J. Schwartz,et al.  Is the absence of a normal nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage? , 1997, Journal of hypertension.

[3]  Giuseppe Mancia,et al.  Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy , 1997 .

[4]  R H Fagard,et al.  Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. , 1997, Hypertension.

[5]  J. Staessen,et al.  Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis , 1996, Journal of hypertension.

[6]  J. Robinson,et al.  Reproducibility of the circadian blood pressure fall at night in healthy young volunteers. , 1996, Journal of human hypertension.

[7]  J. Potter,et al.  Reproducibility of the circadian systolic blood pressure variation in the elderly , 1995, Journal of hypertension.

[8]  S. Rosansky,et al.  The effect of sleep intervals on analysis of 24-h ambulatory blood pressure data. , 1995, American journal of hypertension.

[9]  R. Schmieder,et al.  Improved classification of dippers by individualized analysis of ambulatory blood pressure profiles. , 1995, American journal of hypertension.

[10]  G. Reboldi,et al.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.

[11]  R. Bigazzi,et al.  Diurnal variations of blood pressure and microalbuminuria in essential hypertension. , 1994, American journal of hypertension.

[12]  W. Meyer-Sabellek,et al.  Relationships between ambulatory blood pressure, forearm vascular resistance, and left ventricular mass in hypertensive and normotensive subjects. , 1993, American journal of hypertension.

[13]  G Mancia,et al.  Autonomic modulation of the cardiovascular system during sleep. , 1993, The New England journal of medicine.

[14]  G. Parati,et al.  Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. , 1992, Hypertension.

[15]  K. Shimada,et al.  Silent Cerebrovascular Disease in the Elderly Correlation With Ambulatory Pressure , 1990, Hypertension.

[16]  G. Schillaci,et al.  Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. , 1990, Circulation.

[17]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[18]  J. Laragh,et al.  Standardization of M-mode echocardiographic left ventricular anatomic measurements. , 1984, Journal of the American College of Cardiology.

[19]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[20]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[21]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .